TCL Archive President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel June 1, 2001
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Annual Report Finds Cancer Incidence And Death Rates Fell For First Time. December 5, 2008
